Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* We plan to enroll 300 clopidogrel users without baseline gastroduodenal ulcer at initial endoscopy. The patients will be randomly assigned to receive either (1) esomeprazole (20 mg qd) plus clopidogrel or (2) clopidogrel treatment alone for 6 months.~Exclusion Criteria:~* 1.serious disease 2.refuse informed consent

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Esomeprazole plus clopidogrel group (Type: ACTIVE_COMPARATOR): esomeprazole (20 mg qd) plus clopidogrel (75 mg qd) for 6 months
- Clopidogrel group (Type: NO_INTERVENTION): clopidogrel 75 mg qd for 6 months

Based on this trial design, predict the completion outcome and termination type (if applicable).